z
NOTE FOR MR B D BR-A-',fTFY
TRANSDERMAL NTCOTLYE
The following has occured:-
1. Discussions in Staines with J Rembiszewski, D
Bacon, R Ferris- Decision to
talk to Stowic Resources in further detail.
Transdermal nicotine seen as
'ble parallel activity to cigarette smoking but
legal position needs
possi
clarification.
2. Stowic Resources havc accepted in"ritar;on to
--isit Staines for fimher
discussions (date to be arranged).
3. Prof D Warburton (Reading University) has
agreed to examine Nicotinell
patches in a behavioural study. This will
determine the efficacy of such
patches (in smokers) in terms of performance in
vigilance tasks. The
experiment has been submitted for ethical approval
to Reading University.
4. Nicotinell is likely to be marketed in the U.Y_
shortly. It is possible that it
will require approval by the committee for safety
on medicines. The chairman
(Professor M Rawlins, University of Newcastle) is
known to RET and an
attempt is being made to seek an informal meeting
to ascertain what
considerations the comrnirree might apply to the
use ofnicorine parches.
NB. Nicotinell patches are manufactured by
Ciba-Geigy and are on sale in New
Zealand. Stowic Resources claimed to have
developed a superior product and
approached BAT.
Dr R E Thornton
cc: Mr J Rembiszewski
Mr R P Ferris
Mr D Bacon
Dr L Rudge (Chelwood)
CL)
BATCo document for Province of BritiSh Columbia 26
October 1999